Other secondary endpoints from randomization At randomization, 176/564 (31%) individuals had prediabetes, and 229/564 (41%) met criteria for metabolic syndrome
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al
What states does Willow serve
GLP-1 receptor agonist medications mimic and amplify this hormones effects, binding to receptors throughout the brain, gut, and pancreas
Symptoms associated with NAION may include: Federal GLP-1 litigation is currently divided into two separate multidistrict litigations (MDLs) in the Eastern District of Pennsylvania, where lawsuits involving similar allegations and scientific evidence are being coordinated before a single federal judge
Each area responds differently to non-surgical versus surgical options, so assessment by a clinician should be region-specific